High-level expression of the antimicrobial peptide plectasin in escherichia coli

Current Microbiology

Volumn 61, Issue 3, 2010, Pages 197-202

  Jing, Xiao Lan ^a,b   Luo, Xue Gang ^a,b   Tian, Wen Jing ^a   Lv, Li Hui ^b   Jiang, Yong ^b   Wang, Nan ^b   Zhang, Tong Cun ^b,c,d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Tianjin Key Laboratory of Industrial Microbiology   (China)

^d WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HYBRID PROTEIN; ISOPROPYL THIOGALACTOSIDE; NICKEL; PLASMID VECTOR; PLECTASIN; PROTEINASE; RECOMBINANT PROTEIN; THIOREDOXIN;

AFFINITY CHROMATOGRAPHY; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL LYSATE; CLONING VECTOR; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; GENETIC CODE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECRETION; RECOMBINANT PLASMID; UPREGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; CODON; ESCHERICHIA COLI; GENE EXPRESSION; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PLASMIDS; RECOMBINANT FUSION PROTEINS; THIOREDOXINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FUNGI; MAMMALIA; POSIBACTERIA; PSEUDOPLECTANIA NIGRELLA; STREPTOCOCCUS PNEUMONIAE;

EID: 77956181718     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-010-9596-3     Document Type: Article

References (20)

1. EL Snary LA Kelly HC Davison, et al. 2004 Antimicrobial resistance: a microbial risk assessment perspective J Antimicrob Chemother 53 906 917 10.1093/jac/dkh182 1:CAS:528:DC%2BD2cXksVait7g%3D 15102745
2. D Greenwood 1998 Resistance to antimicrobial agents: a personal view J Med Microbiol 47 751 755 10.1099/00222615-47-9-751 1:STN:280: DyaK1cvgsFGlsA%3D%3D 9736155
3. PH Mygind RL Fischer KM Schnorr, et al. 2005 Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus Nature 437 975 980 10.1038/nature04051 1:CAS:528:DC%2BD2MXhtV2ktrvF 16222292
4. KS Brinch A Sandberg P Baudoux, et al. 2009 Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in the mouse peritonitis model Antimicrob Agents Chemother 53 4801 4808 10.1128/AAC.00685-09 1:CAS:528:DC%2BD1MXhtl2itLbE 19738011
5. S Hara H Mukae N Sakamoto, et al. 2008 Plectasin has antibacterial activity and no affect on cell viability or IL-8 production Biochem Biophys Res Commun 374 709 713 10.1016/j.bbrc.2008.07.093 1:CAS:528:DC%2BD1cXhtValsr3I 18675251
6. C Ostergaard D Sandvang N Frimodt-Møller, et al. 2009 High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis Antimicrob Agents Chemother 53 1581 1585 10.1128/AAC.01202-08 19188395
7. AL Demain P Vaishnav 2009 Production of recombinant proteins by microbes and higher organisms Biotechnol Adv 27 297 306 10.1016/j.biotechadv.2009.01.008 1:CAS:528:DC%2BD1MXisFSqu7c%3D 19500547
8. RM Horton 1995 PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes Mol Biotechnol 3 93 99 10.1007/BF02789105 1:CAS:528:DyaK2MXmtFGlu70%3D 7620981
9. QF Zhou XG Luo L Ye, et al. 2007 High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression Curr Microbiol 54 366 370 10.1007/s00284-006-0466-y 1:CAS:528:DC%2BD2sXltVGqs7Y%3D 17486407
10. K Garai SL Crick SM Mustafi, et al. 2009 Expression and purification of amyloid-beta peptides from Escherichia coli Protein Expr Purif 66 107 112 10.1016/j.pep.2009.02.009 1:CAS:528:DC%2BD1MXksVCgsrw%3D 19233290
11. M He L Jin B Austen 1993 Specificity of factor Xa in the cleavage of fusion proteins J Protein Chem 12 1 5 10.1007/BF01024906 8427626
12. EP Feener T Shiba KQ Hu, et al. 1994 Characterization of phorbol ester-stimulated serine phosphorylation of the human insulin receptor Biochem J 303 43 50 1:CAS:528:DyaK2cXlvFKntL8%3D 7945263
13. H Schägger 2006 Tricine-SDS-PAGE Nat Protoc 1 16 21 10.1038/nprot.2006.4 17406207
14. RI Lehrer M Rosenman SSSL Harwig, et al. 1991 Ultra sensitive assays for endogenous antimicrobial polypeptides J Immunol Methods 137 167 173 10.1016/0022-1759(91)90021-7 1:CAS:528:DyaK3MXisVGmtrc%3D 1901580
15. H Jenssen P Hamill RE Hancock 2006 Peptide antimicrobial agents Clin Microbiol Rev 19 491 511 10.1128/CMR.00056-05 1:CAS:528:DC%2BD28XosVaqsrk%3D 16847082
16. JH Wong L Xia TB Ng 2007 A review of defensins of diverse origins Curr Protein Pept Sci 8 446 459 10.2174/138920307782411446 1:CAS:528: DC%2BD2sXhtlSisbzO 17979760
17. JF Kane 1995 Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli Curr Opin Biotechnol 6 494 500 10.1016/0958-1669(95)80082-4 1:CAS:528:DyaK2MXovVarsb0%3D 7579660
18. D Mustacich G Powis 2000 Thioredoxin reductase Biochem J 346 1 8 10.1042/0264-6021:3460001 1:CAS:528:DC%2BD3cXhsF2isrw%3D 10657232
19. CH Williams Jr 1995 Mechanism and structure of thioredoxin reductase from Escherichia coli FASEB J 9 1267 1276 1:CAS:528:DyaK2MXovVGnsbw%3D 7557016
20. K Terpe 2003 Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems Appl Microbiol Biotechnol 60 523 533 1:CAS:528:DC%2BD3sXjvFGntQ%3D%3D 12536251